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Tikhonenko et al. (1) recently reported that dia-betes-induced changes in retinal fatty acid me-tabolism lead to a significant decrease in retinaln-3 polyunsaturated fatty acids (PUFAs), espe-
cially docos ahex aenoic acid (DHA). They proposed that
these changes in fatty acid compositions may be related to
the chronic inflammation that occurs in the diabetic retina.
Even though they admitted it was possible that high levels
of reactive oxygen species (ROS) cause the degradation of
the highly oxidation-prone DHA molecule, Tikhonenko et al.
concluded that altered fatty acidmetabolismwas responsible
for such retina-specific fatty acid changes.
Recently, we reported that hard exudates in the human
diabetic retina, which are believed to develop as a result of
extravasation of plasma lipids, have lower levels of DHA
and eicosapentaenoic acid than plasma lipids (2). This fact
implies that oxidation-prone PUFAs, including DHA, in
hard exudates may be more readily degraded (peroxi-
dized) by high levels of ROS. We thus proposed that these
alterations of the fatty acid composition may be another
pathophysiological explanation for the existing chronic
inflammatory conditions in the diabetic retina. Both the
reduction of anti-inflammatory effects caused by the dec-
rement of long-chain PUFAs and the accumulation of lipid
peroxidation products from degraded PUFA, which have a
chemotactic effect on inflammatory cells (macrophages)
and are directly toxic to capillary or retina tissues, may be
other possible proinflammatory mechanisms in the dia-
betic retina (3).
Even with recent studies of the potential cardioprotec-
tive effects of n-3 PUFA, whether PUFA supplements
could be beneficial for diabetic patients is still controver-
sial. Theoretically, increased proportions of oxidation-
prone PUFA in lipids may be related to enhanced
susceptibility to oxidative stress, especially under hyper-
glycemic conditions, which promote localized oxidative
stress in tissues vulnerable to diabetic damage. Vascular
damage and related vascular leakage of plasma contents
are an important pathological mechanism of diabetic
retinopathy, and accumulated substances in the extracel-
lular space are known to be highly liable to oxidative
damage. Thus, modification of dietary intake of n-3 PUFA
in patients with diabetic retinopathy should be evaluated
with caution, keeping in mind the potential risks for
peroxidation of the accumulated PUFA in the diabetic
retina (4).
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